GGHC
Gilder Gagnon Howe & Co’s Phathom Pharmaceuticals PHAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Sell |
31,358
-10,208
| -25% | -$97.9K | ﹤0.01% | 230 |
|
|
2025
Q1 | $261K | Sell |
41,566
-44
| -0.1% | -$276 | ﹤0.01% | 225 |
|
|
2024
Q4 | $338K | Sell |
41,610
-1,581,273
| -97% | -$12.8M | ﹤0.01% | 239 |
|
|
2024
Q3 | $29.3M | Buy |
1,622,883
+150,624
| +10% | +$2.72M | 0.35% | 70 |
|
|
2024
Q2 | $15.2M | Buy |
1,472,259
+454,642
| +45% | +$4.68M | 0.19% | 98 |
|
|
2024
Q1 | $10.8M | Sell |
1,017,617
-437,515
| -30% | -$4.65M | 0.14% | 114 |
|
|
2023
Q4 | $13.3M | Buy |
1,455,132
+145,084
| +11% | +$1.32M | 0.18% | 105 |
|
|
2023
Q3 | $13.6M | Buy |
1,310,048
+249,443
| +24% | +$2.59M | 0.21% | 92 |
|
|
2023
Q2 | $15.2M | Buy |
1,060,605
+506,776
| +92% | +$7.26M | 0.21% | 95 |
|
|
2023
Q1 | $3.95M | Buy |
553,829
+2,002
| +0.4% | +$14.3K | 0.07% | 146 |
|
|
2022
Q4 | $6.19M | Sell |
551,827
-615
| -0.1% | -$6.9K | 0.12% | 126 |
|
|
2022
Q3 | $6.12M | Sell |
552,442
-3,663
| -0.7% | -$40.6K | 0.11% | 123 |
|
|
2022
Q2 | $4.69M | Sell |
556,105
-188
| -0% | -$1.59K | 0.08% | 138 |
|
|
2022
Q1 | $7.57M | Buy |
556,293
+10,238
| +2% | +$139K | 0.07% | 154 |
|
|
2021
Q4 | $10.7M | Sell |
546,055
-4,185
| -0.8% | -$82.3K | 0.06% | 174 |
|
|
2021
Q3 | $17.7M | Buy |
550,240
+3,718
| +0.7% | +$119K | 0.09% | 164 |
|
|
2021
Q2 | $18.5M | Sell |
546,522
-271,863
| -33% | -$9.2M | 0.09% | 167 |
|
|
2021
Q1 | $30.7M | Buy |
+818,385
| New | +$30.7M | 0.17% | 129 |
|